 |
A quick and simple in vitro assay to predict bioavailability of actinides following accidental exposure |
Van der Meeren A, Angulo JF, Bohand S, Griffiths NM |
|
 |
 |
Americium biodistribution in rats after wound contamination with different physicochemical forms in the presence or absence of plutonium: analyses using STATBIODIS |
Lamart S, Van der Meeren A, Grémy O, Miccoli L, Coudert S, Dubois S, Bibard S, Serond AP, Angulo JF, Griffiths NM |
|
 |
 |
Comments on actinide radiotoxicology research and the 3Rs remit – Replace, Reduce and Refine |
Griffiths N M., Van der Meeren A., Angulo JF |
BIO Web of Conferences 14 HEIR 2018, 2019, 1-2 |
 |
 |
"Exploiting the ""Rat Actinide Repository"" at the Laboratory of Radio Toxicology, CEA, France" |
Griffiths NM., Stéphanie L, Humbert A-C, Van der Meeren A |
BIO Web of Conferences 14 HEIR 2018, 2019, 1-2 |
 |
 |
From in vivo to in vitro models to assess bioavailability properties of Plutonium compounds |
Grémy O., Griffiths NM., Miccoli L., and Van der Meeren A |
BIO Web of Conferences 14 HEIR 2018, 2019, 1-2 |
 |
 |
Influence of the physico-chemical form on americium biodistribution after wound contamination: re-analysis of experimental data using STATBIODIS |
Lamart S., Van der Meeren A., Dubois S., Bibard S., Serond AP., Angulo JF., and Griffiths NM |
BIO Web of Conferences 14 HEIR 2018, 2019, 1-2 |
 |
 |
Medical countermeasures against radionuclide contamination: An overview |
|
BIO Web of Conferences 14 HEIR 2018, 2019, 1-2 |
 |
 |
Method for detecting and characterizing actinide-bearing micro-particles in soils and sediment of the Fukushima Prefecture, Japan |
Jaegler H, Pointurier F, Onda Y, Angulo J.F., Griffiths NM, Moureau A, Faure A-L, Marie O, Hubert A., Evrard· O |
|
 |
 |
Répondre aux risques NRBC. Prise en charge thérapeutique suite à une contamination radiologique |
Van der Meeren A et Legallic C. |
|
 |
 |
Toxicity mechanisms of cobalt oxide particles (Co3O4P) on human lung cells: impact of solubilization |
Malard V., Bresson C., Uboldi C., Delangle P., Van der Meeren A., Lemaire D., Darolles C., Orsière T., Ortega R., and Berthomieu C |
BIO Web of Conferences 14 HEIR 2018, 2019, 1-2 |
 |
 |
Actinide-contaminated Skin: Comparing Decontamination Efficacy of Water, Cleansing Gels, and DTPA Gels |
Tazrart A, Bolzinger MA, Lamart S, Coudert S, Angulo JF, Jandard V, Briançon S, Griffiths NM |
|
 |
 |
Towards the development of chitosan nanoparticles for plutonium pulmonary decorporation |
Léost L, Roques J, Van Der Meeren A, Vincent L, Sbirrazzuoli N, Hennig C, Rossberg A, Aupiais J, Pagnotta S, Den Auwer C, Di Giorgio C |
|
 |
 |
Delivery of DTPA through Liposomes as a Good Strategy for Enhancing Plutonium Decorporation Regardless of Treatment Regimen. |
Gremy O, Miccoli L, Lelan F, Bohand S, Cherel M, Mougin-Degraef M. |
|
 |
 |
Actinide bioimaging in tissues: comparison of emulsion and solid track autoradiography techniques with the iQID camera. |
Lamart S, Miller BW, Van der Meeren A, Tazrart A, Angulo J. F, and Griffiths N M. |
|
 |
 |
Analysis methodology and development of a statistical tool for biodistribution data from internal contamination with actinides. |
Lamart S., Griffiths N.M., Tchitchek N., Angulo J.F, Van der Meeren A. |
|
 |
 |
Decorporation Approach after Rat Lung Contamination with Plutonium: Evaluation of the Key Parameters Influencing the Efficacy of a Protracted Chelation Treatment. |
Gremy O., Coudert S., Renault D., Miccoli L. |
|
 |
 |
Skin absorption of actinides: influence of solvents or chelates on skin penetration ex vivo. |
Tazrart A., Bolzinger MA., Coudert S., Lamart S., Miller B.W., Angulo J.F., Briançon S., Griffiths N.M. |
|
 |
 |
Body size-specific effective dose conversion coefficients for ct scans. |
Romanyukha A., Folio L., Lamart S., Simon S.L., Lee C. |
|
 |
 |
Decorporation of Pu/Am Actinides by Chelation Therapy: New Arguments in Favor of an Intracellular Component of DTPA Action. |
Gremy O., Laurent D., Coudert S., Griffiths N.M., Miccoli L. |
|
 |
 |
In vitro assessment of plutonium uptake and release using the human macrophage-like THP-1 cells. |
Van der Meeren A, Moureau A, Laurent D, Laroche P, Angulo JF |
|
 |
 |
Organ Dose Estimates for Hyperthyroid Patients Treated with (131)I: An Update of the Thyrotoxicosis Follow-Up Study. |
Melo D.R., Brill A.B., Zanzonico P., Vicini P., Moroz B., Kwon D., Lamart S., Brenner A., Bouville A., Simon S.L. |
|
 |
 |
Penetration and decontamination of americium-241 ex vivo using fresh and frozen pig skin. |
Tazrart A., Bolzinger M.A., Moureau A., Molina T., Coudert S., Angulo J.F., Briancon S., Griffiths N.M. |
|
 |
 |
Reconstruction of organ dose for external radiotherapy patients in retrospective epidemiologic studies. |
Lee C., Jung J.W., Pelletier C., Pyakuryal A., Lamart S., Kim J.O., Lee C. |
|
 |
 |
A threshold of endogenous stress is required to engage cellular response to protect against mutagenesis |
Saintigny Y, Chevalier F, Bravard A, Dardillac E, Laurent D, Hem S, Depagne J, Radicella JP2, Lopez BS |
|
 |
 |
Kin17 facilitates multiple double-strand break repair pathways that govern B cell class switching. |
Le M., Haddad D., Ling A., Li C., So C., Chopra A., Hu R., Angulo J.F., Moffat J. and Martin A. |
|
 |
 |
S values for 131I based on the ICRP adult voxel phantoms. |
Lamart S., Simon SL., Bouville A., Moroz B.E., Lee C. |
|
 |
 |
Forecasting the in vivo behavior of radiocontaminants of unknown physicochemical properties using a simple in vitro test |
Griffiths NM, Coudert S, Moureau A, Laroche P, Angulo JF, Van der Meeren A. , |
|
 |
 |
Developing a physiologically based approach for modeling plutonium decorporation therapy with DTPA |
Kastl M, Giussani A, Blanchardon E, Breustedt B, Fritsch P, Hoeschen C, Lopez MA |
|
 |
 |
Medical countermeasures after a radiological event An update from the CATO project |
Leiterer A, Bardot I, Menetrier F, Bardot S, Gremy O, Berard P, Pech A, Favaro P |
|
 |
 |
Actinide handling after wound entry with local or systemic decorporation therapy in the rat |
Griffiths NM, Coudert S, Renault D, Wilk JC, van der Meeren A |
|
 |